Tilray | TRLY - Capital De Empréstimo

Preço das Ações
8.43
Mudança Diária
-0.53 -5.92%
Mensal
0.96%
Anual
1,139.71%
Q2 Previsão
9.04




Capital De Empréstimo Alterar Data
Acasti Pharma USD 0 0 2024-12
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Avita Medical AUD 42.24M 1.25M 2024-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Moderna USD 610M 584M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Zealand Pharma A/S 383.14M 727K 2025-12